|
|
||||||||
1From the Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland; the Departments of 2Veterinary Medicine and Surgery, and 3Ophthalmology, University of Missouri, Columbia, Missouri; and the 4Department of Ophthalmology, Doheny Eye Institute, Keck School of Medicine, University of Southern California, Los Angeles, California.
PURPOSE. Microglial cells have been found to play pivotal roles in various neuronal degenerative diseases such as Parkinsons and Alzheimers diseases. Minocycline, a microglial inhibitor, has recently been shown to be neuroprotective in various models of cerebral ischemia and degenerative diseases of the brain. This study was conducted to evaluate the neuroprotective effect of minocycline and the role of microglia in light-induced retinal degeneration.
METHODS. BALB/cJ mice were exposed to intense green light for 3 hours and observed during 1, 3, or 7 days of dark recovery. The animals received intraperitoneal injections of minocycline or vehicle 1 day before exposure to light for 2, 4, or 8 days, depending on the periods of survival. Morphologic, morphometric, immunohistochemical, and electrophysiological studies were performed to evaluate the efficacy of minocycline in the amelioration of light-induced retinal degeneration and the possible involvement of microglial cells.
RESULTS. Minocycline treatment provided marked amelioration in the loss of photoreceptors in light-induced retinal degeneration, as evidenced by morphologic, morphometric, and electrophysiologic criteria. Morphologically, the minocycline-treated group showed markedly better preservation of the outer retina after exposure to light. Morphometrically, at 7 days after exposure to light, in the minocycline-treated animals, 89.1% of the normal-appearing photoreceptor nuclei remained, but in the retinas of the vehicle-control group only 38.0% of these nuclei remained. This difference was statistically significant (P < 0.001). At 7 days after exposure to light electroretinography (ERG) showed that minocycline significantly preserved the amplitudes of dark-adapted a- and b-wave and light-adapted b-wave, which were all significantly reduced after exposure to light. Concomitant with this protective effect, at 3 days after exposure to light, the CD11b+ microglial cells in the outer nuclear layer (ONL) and subretinal space in the minocycline-treated group were significantly decreased (by 63.5%) when compared with those in the light-exposed, vehicle-treated control group (P < 0.01).
CONCLUSIONS. Minocycline is neuroprotective against light-induced loss of photoreceptors, possibly through the inhibition of retinal microglial activation.
This article has been cited by other articles:
![]() |
T. Abe, R. Wakusawa, H. Seto, N. Asai, T. Saito, and K. Nishida Topical Doxycycline Can Induce Expression of BDNF in Transduced Retinal Pigment Epithelial Cells Transplanted into the Subretinal Space Invest. Ophthalmol. Vis. Sci., August 1, 2008; 49(8): 3631 - 3639. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-q. Ni, G.-z. Xu, W.-z. Hu, L. Shi, Y.-w. Qin, and C.-d. Da Neuroprotective Effects of Naloxone against Light-Induced Photoreceptor Degeneration through Inhibiting Retinal Microglial Activation Invest. Ophthalmol. Vis. Sci., June 1, 2008; 49(6): 2589 - 2598. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-p. Yang, X.-a. Zhu, and M. O. M. Tso Role of NF-{kappa}B and MAPKs in Light-Induced Photoreceptor Apoptosis Invest. Ophthalmol. Vis. Sci., October 1, 2007; 48(10): 4766 - 4776. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Joly, V. Pernet, S. Chemtob, A. Di Polo, and P. Lachapelle Neuroprotection in the Juvenile Rat Model of Light-Induced Retinopathy: Evidence Suggesting a Role for FGF-2 and CNTF Invest. Ophthalmol. Vis. Sci., May 1, 2007; 48(5): 2311 - 2320. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Leung, L. A. Lindlief, A. Laabich, G. P. Vissvesvaran, M. Kamat, K. L. Lieu, A. Fawzi, and R. Kubota Minocycline Protects Photoreceptors from Light and Oxidative Stress in Primary Bovine Retinal Cell Culture Invest. Ophthalmol. Vis. Sci., January 1, 2007; 48(1): 412 - 421. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Samardzija, A. Wenzel, S. Aufenberg, M. Thiersch, C. Reme, and C. Grimm Differential role of Jak-STAT signaling in retinal degenerations FASEB J, November 1, 2006; 20(13): 2411 - 2413. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Joly, V. Pernet, A. L. Dorfman, S. Chemtob, and P. Lachapelle Light-induced retinopathy: comparing adult and juvenile rats. Invest. Ophthalmol. Vis. Sci., July 1, 2006; 47(7): 3202 - 3212. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Lei, G. Yao, K. Zhang, K. J. Hofeldt, and B. Chang Study of rod- and cone-driven oscillatory potentials in mice. Invest. Ophthalmol. Vis. Sci., June 1, 2006; 47(6): 2732 - 2738. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Levkovitch-Verbin, M. Kalev-Landoy, Z. Habot-Wilner, and S. Melamed Minocycline delays death of retinal ganglion cells in experimental glaucoma and after optic nerve transection. Arch Ophthalmol, April 1, 2006; 124(4): 520 - 526. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-y. Zeng, X.-a. Zhu, C. Zhang, L.-P. Yang, L.-m. Wu, and M. O. M. Tso Identification of Sequential Events and Factors Associated with Microglial Activation, Migration, and Cytotoxicity in Retinal Degeneration in rd Mice Invest. Ophthalmol. Vis. Sci., August 1, 2005; 46(8): 2992 - 2999. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Krady, A. Basu, C. M. Allen, Y. Xu, K. F. LaNoue, T. W. Gardner, and S. W. Levison Minocycline Reduces Proinflammatory Cytokine Expression, Microglial Activation, and Caspase-3 Activation in a Rodent Model of Diabetic Retinopathy Diabetes, May 1, 2005; 54(5): 1559 - 1565. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |